CMV-Specific CD8+ T-CELL Function Is NOT Impaired In CLL
Raa D,Pascutti F,Garcia-Vallejo J et al.




Key Points:
  • Increased expression of exhaustion markers PD-1, CD160 and CD244 on CLL-derived total CD8+ T cells.

  • Significantly lower expression of these markers on CMV-tetramer+CD8+ T cells in CLL patients.

  • Analyzed functionality of CMV-specific CD8+ T cells.

  • No differences between CLL patients and age-matched HC as to IFNγ, TNFα and IL-2 production by CMV-tetramer+CD8+ cells.

  • Fraction of CMV-tetramer+CD8+ T cells producing cytokines also did not differ.

  • CMV-specific CD8+ T cells from CLL patients as effective as those from HC in killing CMV-peptide-loaded EBV-LCLs at varying effector:target ratios.

  • Percentages of CD8+T cells forming specific proper IS with CMV-peptide loaded EBV-LCLs comparable in CLL and HC T cells (around 45%).

Implications:

  • CMV-specific CD8+ T cells derived from CLL patients have lower expression of exhaustion markers and are functionally intact.

View the original abstract on the ASH website.






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements